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Dedication ((optional)) 
Abstract: A new catalytic reaction to synthesize structurally complex 
hexahydrochromeno[2,3-b]pyrrole derivatives from simple 3-
butynamine and 2-(hydroxymethyl)phenol derivatives is described. 
The process is promoted by a dual catalytic system formed by a gold 
complex and a Lewis acid (boron trifluoride). The reaction involves 
the synchronized transformation of the starting materials into two 
reactive intermediates, a cyclic enamine derivative and an ortho-
quinone methide, that subsequently react between them through a 
formal [4+2] cycloaddition to furnish the final poly-heterocyclic 
product in a straightforward way.  
Introduction 
In recent years, the development of new chemical 
transformations involving the intermediacy of ortho-quinone 
methides (o-QM) has experienced a considerable growth.[1] This 
kind of reactive species are usually in situ generated by 
treatment of appropriate precursors under acidic[2] or basic[3] 
conditions. They can be also accessed by elimination reactions 
promoted by different agents,[4] or through thermal processes.[5] 
Regarding the reactivity of o-QMs, they have been mainly used 
as heterodienes in cycloaddition processes.[4a,6] In this type of 
reactions, the corresponding o-QM is in situ generated in the 
presence of suitable cycloaddition partners. Moreover, the 
development of reactions where both the o-QM and the 
dienophile are catalytically and simultaneously generated, is an 
appealing research field. In this context, a gold-catalysed 
process recently reported by our group is to be mentioned 
(Scheme 1a).[7] In this reaction, the gold catalyst promotes the 
formation of enamines I (a dienophile) from alkynamines 1 and 
also the generation of isochromanone II (a heterodiene) from 
ortho-alkynylsalicylaldehyde 2. The subsequent reaction 
between intermediates I and II leads to pyranochromeno[2,3-
b]pyrrole derivatives 3. In this context, we envisioned that 2-
(hydroxymethyl)phenol derivatives 4 could be suitable 
precursors of o-QMs III (Scheme 1b). Since o-QMs usually 
behave as heterodienes in formal cycloaddition processes, 
intermediates III should react with cyclic enamines I delivering 
hexahydrochromeno[2,3-b]pyrrole derivatives 5. In contrast with 
our previous work, the planned reaction would require two 
different catalysts to promote the formation of the heterodiene III 
and dienophile I.[8] 
 
 
Scheme 1. Previous work and the new proposal for the synthesis of 
hexahydrochromeno[2,3-b]pyrrole derivatives. 
With all this in mind, we initiated our investigation to find 
appropriate catalysts and conditions to perform the desired 
transformation. For the initial experiments, we selected tert-butyl 
[4-(4-bromophenyl)but-3-yn-1-yl]carbamate 1a and 2-
[hydroxyl(phenyl)methyl]phenol 4a as model substrates. For the 
in-situ generation of the corresponding enecarbamates I from 1a 
different gold catalysts were considered. On the other hand, the 
dehydration reaction of 4a to obtain the corresponding o-QM III 
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would require a Brønsted or Lewis acid as catalyst. In this sense, 
it should be noted that the use of binary metal / Brønsted acid 
catalytic systems are well documented in the bibliography and 
represents an appealing field to which our research group has 
recently contributed.[9,10] For this reason, we started our 
investigation by trying the model reaction in the presence of 
(JohnPhos)AuNTf2 (5 mol%) as the gold-catalyst and different 
Brønsted acids (5 mol%) including triflic acid, tetrafluoroboric 
acid and diphenylphosphate among others. Although in some 
cases we observed the formation of the desired 
hexahydrochromeno[2,3-b]pyrrole 5a, neither the yield nor the 
reproducibility were good. 
 
Scheme 2. Proof of concept and initial result. 
At this point, we turned our attention to the use of a Lewis acid in 
combination with the gold-catalyst. It should be noted that this 
type of binary catalytic systems has been lesser used than those 
others formed by a gold-catalyst and a Brønsted acid.[11] 
However, after some experimentation we found that 
(JohnPhos)AuNTf2 / BF3·OEt2 was an appropriate catalytic 
system to promote the target transformation (Scheme 2). Thus, 
when diol 1a and alkynamine 4a (2 equiv) were reacted in 
dichloromethane at room temperature in the presence of 5 mol% 
of (JohnPhos)AuNTf2 and 10 mol% of BF3·OEt2 we observed the 
formation of hexahydrochromeno[2,3-b]pyrrole 5a in almost 
quantitative yield (98%). Noteworthy, three new bonds and three 
stereogenic centres were created in this transformation. 
Furthermore, 5a was obtained as a single diastereoisomer and 
the reaction could be scaled up to synthesize 2.15 grams of 
hexahydrochromeno[2,3-b]pyrrole 5a in one batch without 
observing major changes in yield or diastereoselectivity. The 
structure of 5a was determined by NMR studies and confirmed 
X-ray diffraction analysis.[12]  
 
Results and Discussion 
Having identified the optimized reaction conditions, we next 
studied the scope of the transformation using a series of 
substrates with different substitution patterns (Scheme 3). For 
the first set of experiments we used different 2-
(hydroxymethyl)phenol derivatives 4 substituted with an 
aromatic group (Ar2) in combination with a series of alkynamine 
derivatives 1 also substituted at the terminal position of the 
alkyne with an aromatic ring (Ar1). Thus, as far as seventeen 
different hexahydrochromeno[2,3-b]pyrrole derivatives 5 could 
be accessed in good yields and as single diastereoisomers in 
most of the cases. In those cases where two diastereoisomers 
were obtained, the structure of the minor one differs from that of 
the major one only in the relative configuration of the 
stereocenter at 4-position (Scheme 3). 
 
Scheme 3. Scope of the reaction with different arene-substituted 2-
(hydroxymethyl)phenol derivatives 4. 
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These results demonstrated that a wide range of substitution 
pattern was well tolerated. Thus, diverse substitution (ortho, 
meta, para and disubstitution) was allowed on the aromatic ring 
(Ar1) of the initial alkynamine derivative 1. However, we were not 
able to isolate the corresponding hexahydrochromeno[2,3-
b]pyrrole derivatives when the alkynamine derivative 1 was 
unsubstituted at the terminal position of the alkyne or substituted 
with an alkyl group. Although most of the experiments were 
performed with alkynamine derivative 1 substituted with a tert-
butoxycarbonyl group (Boc) on the nitrogen atom, we proved 
that other substituents such as a methoxycarbonyl (5h,j) or a 
tosyl group (5i) were also allowed. Regarding the substitution of 
the 2-(hydroxymethyl)phenol 4, reactions with starting materials 
containing different aromatic rings (Ar2) and substituents on the 
central arene (R’) were successfully accomplished. 
In order to expand the scope of the transformation we performed 
a second set of experiments with alkyne-containing 2-
(hydroxymethyl)phenol derivatives 6 (Scheme 4). These 
precursors of o-QMs III are particularly interesting as they 
should lead to a new type of alkyne-substituted 
hexahydrochromeno[2,3-b]pyrrole derivatives 7 that could be 
further functionalized through reactions involving the carbon-
carbon triple bond. 
 
Scheme 4. Scope of the reaction with different alkyne-substituted 2-
(hydroxymethyl)phenol derivatives 6. 
As shown, under the optimized reaction conditions previously 
found, we were able to obtain a series of products 7 in good to 
excellent yields but in these cases as mixtures of two 
diastereoisomers with selectivities ranging from 3:1 to 1:1 
(Scheme 4). The structure of the major diastereoisomer is 
shown in scheme 4 while the minor diastereoisomer differs in 
the relative configuration of the stereocenter at propargylic 
position. Though, apart from aromatic rings (7a-d) and aliphatic 
groups (7e), the reaction tolerates the presence of other 
interesting substituents at the alkyne moiety of 6 (R1). Thus, 
products with a cyclopropyl (7f), a trimethylsilyl (7g) or a 
cyclohexenyl (7i) could be isolated in excellent yields. Regarding 
the substitution of alkynamine derivative 1, different aromatic 
rings (Ar1) including heteroaromatics (7e) were tolerated at the 
alkynamine derivative 1. As before, we were not able to obtain 
the desired hexahydrochromeno[2,3-b]pyrrole derivatives when 
the alkynamine derivative 1 was unsubstituted at the terminal 
position of the alkyne or substituted with an alkyl group. Finally, 
the tert-butoxycarbonyl (Boc) substituent on the nitrogen of 
alkynamine 1 could be replaced by methoxycarbonyl or tosyl 
groups (7h,i).  
A plausible mechanism for the formation of 
hexahydrochromeno[2,3-b]pyrrole derivatives 5 (or 7) involving 
three independent catalytic cycles is shown in Scheme 5. 
 
Scheme 5. Mechanistic proposal. 
In the first catalytic cycle, the Lewis acid (BF3) coordinates the 
alcohol functionality of 2-(hydroxymethyl)phenol derivatives 4 to 
form the new species 8. This coordination favours a dehydration 
reaction to generate the ortho-quinone methide (o-QM) 
derivative 9 in a process where the Lewis acid is regenerated. 
Simultaneously, the gold catalyst, JohnPhosAuNTf2, coordinates 
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favours a 5-endo addition of the nitrogen atom to the alkyne to 
form intermediate 11. A final protodemetalation step closes the 
second catalytic cycle affording the enamine derivative 12 and 
regenerating the gold catalyst. At this point, we propose that o-
QM 9 enters a new catalytic cycle where the Lewis acid (BF3) 
coordinates to the oxygen atom as shown in 13. We propose 
that this coordination favours the subsequent formal [4+2] 
cycloaddition reaction of this adduct 13 with enamine derivative 
12 to afford the hexahydrochromeno[2,3-b]pyrrole derivatives 5 
regenerating the Lewis acid catalyst. The relative configuration 
observed at the new stereogenic centres in the single or major 
diastereoisomer of 5 could be explained through an endo 
approach of the dienophile and the diene as shown in A (endo 
refers to the orientation of the nitrogen in dienophile 12 with 
respect to the diene 13). Interestingly, the global process could 
be considered a particular type of metal / Lewis acid relay one 
pot catalysis with two different catalysts and three independent 
catalytic cycles.[13] 
Conclusions 
In conclusion, a new protocol for the synthesis of 
hexahydrochromeno[2,3-b]pyrrole derivatives from simple 3-
butynamine and 2-(hydroxymethyl)phenol derivatives has been 
developed. The reaction required the use of a dual catalytic 
system consisting of a gold complex and a Lewis acid, boron 
trifluoride. The cited catalytic system promotes the in-situ 
formation of an enecarbamate and an ortho-quinone methide 
that subsequently suffer a formal [4+2] cycloaddition reaction to 
yield the final product. The reaction is shown to be 
straightforward, high-yielding and easy to scale-up, while it 
paves the way for interesting poly-heterocyclic products, which 
are otherwise difficult to obtain. 
Experimental Section 
General Procedure for the Synthesis of Hexahydrochromeno[2,3-
b]pyrrole Derivatives 5 or 7: The corresponding alkynylamine 1 (0.3 
mmol, 2 equiv.), diol 4 or 6 (0.15 mmol, 1 equiv.) and 4Å powder 
molecular sieves (25 mg) were placed in an oven-dried Schlenk flask 
under an argon atmosphere. Then, dry dichloromethane (1.5 mL), 
(JohnPhos)AuNTf2 (0.015 mmol, 5 mol%) and BF3·OEt2 (0.015 mmol, 10 
mol%) were sequentially added at 20 oC. The initially colourless solution 
turned reddish and was gently stirred at 20 °C for 15 hours. Then, 2 mL 
of hexane were added to the reaction mixture and the resulting 
suspension was filtered through a path of celite eluting with diethyl ether. 
Solvents were removed under reduced pressure and the crude was 
purified by flash column chromatography on silica gel using mixtures of 
hexane and ethyl acetate as eluent to give the corresponding pure 
products 5 or 7. 
tert-Butyl (3aR*,4R*,9aR*)-9a-(4-bromophenyl)-4-phenyl-2,3,3a,9a-
tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (5a): White solid. 
Rf = 0.51 (hexane/ethyl acetate 5:1). Melting point: 225-227 °C. 1H NMR 
(400 MHz, 330K, CDCl3): δ (ppm) 7.50–7.45 (m, 2H), 7.36–7.22 (m, 6H), 
7.13 (dd, J = 7.9, 1.6 Hz, 2H), 7.05 (d, J = 8.1 Hz, 1H), 6.87–6.83 (m, 2H), 
3.94 (d, J = 5.8 Hz, 1H), 3.84 (app t, J = 9.8 Hz, 1H), 3.51 (td, J = 10.7, 
6.9 Hz, 1H), 2.67 (dt, J = 13.0, 5.8 Hz, 1H), 2.01–1.89 (m, 1H), 1.70–1.61 
(m, 1H), 1.23 (s, 9H). 13C NMR (100 MHz, CDCl3): δ (ppm) 153.5, 153.4, 
142.3, 140.5, 131.2, 129.5, 128.9, 128.5, 128.3, 127.3, 127.1, 121.8, 
121.3, 120.7, 116.3, 94.1, 80.2, 53.4, 46.6, 40.9, 28.0, 23.8. HMRS: 
calculated for C28H28BrNNaO3 [M+Na]+ 528.1144, found 528.1142. 
tert-Butyl (3aR*,4R*,9aR*)-9a-(4-nitrophenyl)-4-phenyl-2,3,3a,9a-
tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (5b): White 
solid. Rf = 0.19 (hexane/ethyl acetate 10:1). Melting point: 229-231 °C. 
1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 8.21 (d, J = 9.0 Hz, 2H), 7.56 
(d, J = 9.0 Hz, 2H), 7.38–7.23 (m, 4H), 7.14–7.05 (m, 3H), 6.91–6.86 (m, 
2H), 3.92–3.82 (m, 2H), 3.55 (td, J = 10.7, 6.9 Hz, 1H), 2.76–2.67 (m, 
1H), 2.07–1.92 (m, 1H), 1.71 (dt, J = 12.5, 6.4 Hz, 1H), 1.22 (s, 9H). 13C 
NMR (100 MHz, 330K, CDCl3): δ (ppm) 153.3, 153.1, 150.5, 147.5, 140.0, 
129.4, 129.0, 128.6, 128.6, 127.3, 126.5, 123.4, 121.6, 121.1, 116.4, 
93.9, 80.7, 53.5, 46.7, 40.9, 28.0, 24.0. HMRS: calculated for 
C28H28N2NaO5 [M+Na]+ 495.1890, found 495.1886. 
tert-Butyl (3aR*,4R*,9aR*)-9a-([1,1'-biphenyl]-4-yl)-4-phenyl-
2,3,3a,9a-tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (5c): 
White solid. Rf = 0.50 (hexane/ethyl acetate 5:1). Melting point: 213-
215 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.66–7.60 (m, 2H), 
7.59–7.55 (m, 2H), 7.49–7.41 (m, 4H), 7.39–7.24 (m, 5H), 7.16 (dd, J = 
7.9, 1.5 Hz, 2H), 7.10 (d, J = 8.0 Hz, 1H), 6.90–6.84 (m, 2H), 4.04 (d, J = 
5.2 Hz, 1H), 3.86 (app t, J = 9.8 Hz, 1H), 3.57 (td, J = 10.7, 6.9 Hz, 1H), 
2.85–2.71 (m, 1H), 2.09–1.90 (m, 1H), 1.68 (dt, J = 12.5, 6.4 Hz, 1H), 
1.21 (s, 9H). 13C NMR (100 MHz, 330K, CDCl3): δ (ppm) 153.8, 153.7, 
142.1, 140.8, 140.3, 129.6, 129.0, 128.7, 128.4, 128.3, 127.2, 127.0, 
126.8, 125.9, 121.9, 120.5, 116.4, 94.5, 80.0, 53.5, 46.7, 41.0, 28.0, 23.9. 
HMRS: calculated for C34H33NNaO3 [M+Na]+ 526.2352, found 526.2345. 
tert-Butyl (3aR*,4R*,9aR*)-4-phenyl-9a-(p-tolyl)-2,3,3a,9a-
tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (5d-major 
diast.): White solid. Rf = 0.50 (hexane/ethyl acetate 5:1). Melting point: 
199-201 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.35–7.21 (m, 
6H), 7.16–7.11 (m, 4H), 7.06 (d, J = 8.1 Hz, 1H), 6.86–6.79 (m, 2H), 3.97 
(d, J = 5.0 Hz, 1H), 3.81 (app t, J = 9.8 Hz, 1H), 3.52 (td, J = 10.7, 6.9 Hz, 
1H), 2.77 – 2.63 (m, 1H), 2.37 (s, 3H), 2.01–1.87 (m, 1H), 1.70–1.58 (m, 
1H), 1.20 (s, 9H). 13C NMR (100 MHz, 330K, CDCl3): δ (ppm) 154.0, 
141.2, 140.2, 137.0, 129.8, 129.1, 128.9, 128.6, 128.4, 127.2, 125.6, 
122.2, 120.6, 116.6, 94.8, 80.0, 53.7, 46.9, 41.2, 28.2, 24.1, 21.1. HMRS: 
calculated for C29H31NNaO3 [M+Na]+ 464.2196, found 464.2199. 
tert-Butyl (3aR*,4S*,9aR*)-4-phenyl-9a-(p-tolyl)-2,3,3a,9a-
tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (5d-minor 
diast.): White solid. Rf = 0.34 (hexane/ethyl acetate 5:1). Melting point: 
195-198 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.31–7.25 (m, 
1H,), 7.14 (d, J = 8.0 Hz, 1H), 7.05–6.98 (m, 5H), 6.96–6.92 (m, 2H), 
6.86 (d, J = 8.0 Hz, 2H), 6.79–6.74 (m, 2H), 4.07 (d, J = 3.6 Hz, 1H), 
3.79–3.64 (m, 2H), 3.05–2.97 (m, 1H), 2.23 (s, 3H), 2.21–2.12 (m, 1H), 
1.95–1.85 (m, 1H), 1.20 (s, 9H). 13C NMR (100 MHz, 330K, CDCl3): δ 
(ppm) 153.7, 142.9, 136.2, 130.1, 128.3, 128.2, 128.2, 128.0, 127.8, 
125.8, 125.8, 123.8, 121.3, 117.5, 94.4, 79.7, 54.2, 46.1, 44.3, 28.0, 27.9, 
20.7. HMRS: calculated for C29H31NNaO3 [M+Na]+ 464.2196, found 
464.2195. 
tert-Butyl (3aR*,4R*,9aR*)-9a-(4-methoxyphenyl)-4-phenyl-2,3,3a,9a-
tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (5e-major 
diast.): Yellow solid. Rf = 0.37 (hexane/ethyl acetate 5:1). Melting point: 
206-208 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.26–7.11 (m, 
6H), 7.05–7.01 (m, 2H), 6.95 (d, J = 8.1 Hz, 1H), 6.79–6.71 (m, 4H), 3.87 
(d, J = 5.2 Hz, 1H), 3.77–3.66 (m, 4H), 3.41 (td, J = 10.7, 6.9 Hz, 1H), 
2.58 (dt, J = 13.1, 5.8 Hz, 1H), 1.91–1.76 (m, 1H), 1.57–1.47 (m, 1H), 
1.11 (s, 9H). 13C NMR (100 MHz, 330K, CDCl3): δ (ppm) 159.3, 154.0, 
FULL PAPER    
 
 
 
 
 
141.2, 129.8, 129.2, 128.6, 128.4, 127.2, 126.9, 122.2, 120.6, 116.6, 
113.8, 94.7, 80.0, 55.5, 53.6, 46.9, 41.3, 28.3, 24.0. HMRS: calculated 
for C29H31NNaO4 [M+Na]+ 480.2145, found 480.2147. 
tert-Butyl (3aR*,4S*,9aR*)-9a-(4-methoxyphenyl)-4-phenyl-2,3,3a,9a-
tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (5e-minor 
diast.): Yellow solid. Rf = 0.17 (hexane/ethyl acetate 5:1). Melting point: 
129-131 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.31–7.24 (m, 
1H), 7.12 (d, J = 8.1 Hz, 1H), 7.07–7.00 (m, 5H), 6.95–6.92 (m, 2H), 
6.81–6.72 (m, 2H), 6.62–6.55 (m, 2H), 4.08 (d, J = 3.3 Hz, 1H), 3.77–
3.62 (m, 5H), 3.02 (ddd, J = 10.0, 6.9, 3.5 Hz, 1H), 2.20–2.09 (m, 1H,), 
1.90–1.82 (m, 1H), 1.21 (s, 9H). 13C NMR (100 MHz, 330K, CDCl3): δ 
(ppm) 158.6, 153.6, 143.0, 130.2, 128.3, 128.2, 127.8, 127.1, 125.9, 
121.3, 117.5, 113.0, 94.0, 79.7, 55.3, 54.1, 46.1, 44.2, 28.1, 27.9. HMRS: 
calculated for C29H31NNaO4 [M+Na]+ 480.2145, found 480.2142. 
tert-Butyl (3aR*,4R*,9aR*)-4-(4-methoxyphenyl)-9a-(4-nitrophenyl)-
2,3,3a,9a-tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (5f): 
Yellow solid. Rf = 0.39 (hexane/ethyl acetate 5:1). Melting point: 212-
214 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 8.20 (d, J = 8.7 Hz, 
2H), 7.55 (d, J = 8.7 Hz, 2H), 7.30–7.23 (m, 1H), 7.07 (d, J = 8.0 Hz, 1H), 
7.02 (d, J = 8.5 Hz, 2H), 6.90–6.83 (m, 4H), 3.89–3.77 (m, 5H), 3.55 (td, 
J = 10.6, 7.1 Hz, 1H), 2.74–2.63 (m, 1H), 2.05–1.90 (m, 1H), 1.78–1.68 
(m, 1H), 1.22 (s, 9H). 13C NMR (100 MHz, 330K, CDCl3): δ (ppm) 159.3, 
153.5, 153.3, 150.8, 147.7, 132.2, 130.6, 129.2, 128.8, 126.7, 123.7, 
122.3, 121.4, 116.6, 114.4, 94.2, 80.9, 55.5, 54.0, 47.0, 40.2, 28.3, 24.3. 
HMRS: calculated for C29H30N2NaO6 [M+Na]+ 525.1996, found 525.1992. 
tert-Butyl (3aR*,4R*,9aR*)-4-(4-methoxyphenyl)-9a-[4-
(trifluoromethyl)phenyl)]-2,3,3a,9a-tetrahydrochromeno[2,3-
b]pyrrole-1(4H)-carboxylate (5g): White solid. Rf = 0.46 (hexane/ethyl 
acetate 5:1). Melting point: 219-221 °C. 1H NMR (400 MHz, 330K, 
CDCl3): δ (ppm) δ 7.61 (d, J = 8.2 Hz, 2H), 7.50 (d, J = 8.2 Hz, 2H), 
7.28–7.22 (m, 1H), 7.06 (d, J = 8.7 Hz, 1H), 7.03 (d, J = 8.6 Hz, 2H), 
6.91–6.83 (m, 4H), 3.93–3.79 (m, 5H), 3.55 (td, J = 10.6, 7.0 Hz, 1H), 
2.75–2.61 (m, 1H), 2.05–1.87 (m, 1H), 1.78–1.67 (m, 1H), 1.19 (s, 9H). 
13C NMR (100 MHz, 330K, CDCl3): δ (ppm) δ 159.2, 153.7, 153.6, 147.6, 
132.5, 130.7, 130.0 (q, JCF = 30.0 Hz), 129.2, 128.6, 126.2, 125.3, 124.2 
(q, JCF = 277.2 Hz), 122.4, 121.1, 116.6, 114.3, 94.3, 80.5, 55.5, 53.9, 
46.9, 40.2, 28.2, 24.2. 19F NMR (282 MHz, CDCl3): δ (ppm) 62.4. 
HMRS: calculated for C30H30F3NNaO4 [M+Na]+ 548.2019, found 
548.2024. 
Methyl (3aR*,4R*,9aR*)-9a-(4-bromophenyl)-4-phenyl-2,3,3a,9a-
tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (5h): White 
solid. Rf = 0.50 (hexane/ethyl acetate 5:1). Melting point: 197-199 °C. 1H 
NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.37 (d, J = 8.6 Hz, 2H), 7.25–
7.11 (m, 6H), 7.02 (d, J = 6.4 Hz, 2H), 6.98 (d, J = 8.1 Hz, 1H), 6.77–6.72 
(m, 2H), 3.86 (d, J = 5.2 Hz, 1H), 3.74 (app t, J = 9.8 Hz, 1H), 3.55–3.37 
(m, 4H), 2.68–2.52 (m, 1H), 2.02–1.77 (m, 1H), 1.57 (dt, J = 12.9, 6.6 Hz, 
1H). 13C NMR (100 MHz, 330K, CDCl3): δ (ppm) 154.7, 153.2, 141.1, 
140.4, 131.5, 129.5, 129.0, 128.5, 128.5, 127.2, 121.7, 121.7, 120.9, 
116.5, 94.3, 53.0, 52.2, 46.9, 40.8, 24.1. HMRS: calculated for 
C25H22BrNNaO3 [M+Na]+ 486.0675, found 486.0676. 
(3aR*,4R*,9aR*)-9a-(4-Bromophenyl)-4-phenyl-1-tosyl-1,2,3,3a,4,9a-
hexahydrochromeno[2,3-b]pyrrole (5i): Yellow solid. Rf = 0.66 
(hexane/ethyl acetate 5:1). Melting point: 190-192 °C. 1H NMR (300 MHz, 
CDCl3): δ (ppm) 7.76 (d, J = 8.3 Hz, 2H), 7.42 (d, J = 8.6 Hz, 2H), 7.33–
7.17 (m, 7H), 7.13 (t, J = 7.0 Hz, 1H), 6.98–6.92 (m, 2H), 6.75–6.71 (m, 
3H), 3.77 (d, J = 5.1 Hz, 1H), 3.63–3.43 (m, 2H), 2.68 (dt, J = 12.5, 6.4 
Hz, 1H), 2.39 (s, 3H), 1.85–1.65 (m, 1H), 1.60–1.50 (m, 1H). 13C NMR 
(75 MHz, CDCl3): δ (ppm) 152.8, 143.7, 140.2, 139.7, 136.7, 131.7, 
129.5, 129.1, 128.8, 128.7, 128.7, 128.1, 127.4, 122.6, 121.3, 115.9, 
96.7, 52.7, 47.8, 40.7, 24.0, 21.7. HMRS: calculated for C30H26BrNNaO3S 
[M+Na]+ 582.0708, found 582.0712. 
Methyl (3aR*,4R*,9aR*)-4,9a-diphenyl-2,3,3a,9a-
tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (5j-major 
diast.): White solid. Rf = 0.32 (hexane/ethyl acetate 5:1). Melting point: 
212-214 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.41–7.22 (m, 
9H), 7.15–7.08 (m, 3H), 6.88–6.83 (m, 2H), 3.99 (d, J = 5.2 Hz, 1H), 3.86 
(app t, J = 9.8 Hz, 1H), 3.63–3.51 (m, 4H), 2.81–2.68 (m, 1H), 2.07–1.92 
(m, 1H), 1.68 (dt, J = 12.5, 6.4 Hz, 1H). 13C NMR (100 MHz, 330K, 
CDCl3): δ (ppm) 154.8, 153.5, 141.9, 140.7, 129.5, 128.9, 128.4, 128.3, 
128.2, 127.6, 127.1, 125.3, 121.8, 120.6, 116.5, 94.7, 53.1, 52.0, 47.0, 
40.8, 24.1. HMRS: calculated for C25H23NNaO3 [M+Na]+ 408.1570, found 
408.1576. 
Methyl (3aR*,4S*,9aR*)-4,9a-diphenyl-2,3,3a,9a-
tetrahydrochromeno[2,3-b]pyrrole-1(4H)- carboxylate (5j-minor 
diast.): White solid. Rf = 0.26 (hexane/ethyl acetate 5:1). Melting point: 
142-145 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.31–7.26 (m, 
1H,), 7.20–7.13 (m, 3H), 7.10–7.05 (m, 3H), 7.04–7.00 (m, 3H), 6.96–
6.93 (m, 2H), 6.80–6.74 (m, 2H), 4.10 (d, J = 3.7 Hz, 1H), 3.87–3.64 (m, 
2H), 3.52 (s, 3H), 3.14–2.98 (m, 1H), 2.27–2.12 (m, 1H), 2.00–1.86 (m, 
1H). 13C NMR (75 MHz, 298K, CDCl3): δ (ppm) 153.3, 153.2, 140.7, 
130.3, 129.6, 129.0, 128.5, 128.4, 127.7, 127.1, 125.2, 121.6, 120.7, 
117.6, 116.5, 94.3, 52.3, 46.9, 40.7, 24.0. HMRS: calculated for 
C25H23NNaO3 [M+Na]+ 408.1570, found 408.1576. 
tert-Butyl (3aR*,4R*,9aR*)-9a-(2-fluorophenyl)-4-phenyl-2,3,3a,9a-
tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (5k): White solid. 
Rf = 0.5 (hexane/ethyl acetate 5:1). Melting point: 226-228 °C. 1H NMR 
(400 MHz, 330K, CDCl3): δ (ppm) 7.50 (app t, J = 7.7 Hz, 1H), 7.36–7.23 
(m, 5H), 7.15 (dd, J = 8.0, 1.5 Hz, 2H), 7.12–7.04 (m, 3H), 6.89–6.84 (m, 
2H), 3.98 (d, J = 5.2 Hz, 1H), 3.78 (app t, J = 9.6 Hz, 1H), 3.53 (td, J = 
10.8, 6.7 Hz, 1H), 3.06–2.96 (m, 1H), 2.02–1.85 (m, 1H), 1.71–1.60 (m, 
1H), 1.20 (s, 9H). 13C NMR (100 MHz, 330K, CDCl3): δ (ppm) 158.7 (d, 
JCF = 247.7 Hz), 153.3, 140.6, 129.5, 129.3, 128.8, 128.4, 128.3, 127.1, 
123.8, 121.9, 120.7, 116.4, 115.9 (d, JCF = 22.6 Hz), 92.1, 79.7, 50.1, 
45.8, 41.3, 28.0, 23.9. 19F NMR (282 MHz, CDCl3): δ (ppm) 110.8. 
HMRS: calculated for C28H28FNNaO3 [M+Na]+ 468.1945, found 468.1944. 
tert-Butyl (3aR*,4R*,9aR*)-9a-(2-chlorophenyl)-4-phenyl-2,3,3a,9a-
tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (5l, 
diastereoisomeric mixture): White solid. Rf = 0.66 (hexane/ethyl 
acetate 5:1). Melting point: 226-228 °C. Only representative signals are 
listed: 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.61 (d, J = 8.4 Hz, 1H, 
min diast), 7.54 (d, J = 7.7 Hz, 1H, maj diast), 7.07 (d, J = 8.1 Hz, 1H, 
maj diast), 3.31–3.21 (m, 1H, maj diast), 3.21–3.10 (m, 1H, min diast), 
1.45 (s, 9H, min diast), 1.11 (s, 9H, maj diast). 13C NMR (100 MHz, 330K, 
CDCl3): δ (ppm) 153.3, 153.3, 152.5, 140.6, 138.9, 137.8, 131.5, 131.3, 
130.1, 129.6, 129.4, 129.1, 129.0, 128.8, 128.5, 128.4, 127.1, 126.8, 
121.5, 120.7, 116.4, 116.1, 94.1, 93.5, 79.8, 47.8, 47.2, 45.9, 45.4, 41.1, 
41.0, 28.4, 27.8, 24.6, 24.0. HMRS: calculated for C28H28ClNNaO3 
[M+Na]+ 484.1649, found 484.1649. 
tert-Butyl (3aR*,4R*,9aR*)-9a-(3,5-bis(trifluoromethyl)phenyl)-4-
phenyl-2,3,3a,9a-tetrahydrochromeno[2,3-b]pyrrole-1(4H)-
carboxylate (5m): White solid. Rf = 0.62 (hexane/ethyl acetate 5:1). 
Melting point: 162-164 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 
7.89–7.84 (m, 3H), 7.39–7.27 (m, 4H), 7.14 (dd, J = 7.8, 1.7 Hz, 2H), 
7.10 (d, J = 8.1 Hz, 1H), 6.96–6.86 (m, 2H), 3.93 (d, J = 5.5 Hz, 1H), 3.87 
(app t, J = 10.3 Hz, 1H), 3.59 (td, J = 10.3, 7.0 Hz, 1H), 2.77 (dt, J = 12.3, 
5.5 Hz, 1H), 2.07–1.94 (m, 1H), 1.76 (dt, J = 12.3, 6.4 Hz, 1H), 1.18 (s, 
9H). 13C NMR (100 MHz, 330K, CDCl3): δ (ppm) 153.2, 152.9, 146.6, 
139.7, 131.9 (q, JCF = 33.6 Hz), 129.4, 128.9, 128.7, 128.6, 127.4, 125.9, 
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123.3 (q, JCF = 266.0 Hz), 121.9, 121.4, 116.5, 93.7, 80.7, 53.7, 46.6, 
40.8, 27.8, 23.9. 19F NMR (282 MHz, CDCl3): δ (ppm) 62.8. HMRS: 
calculated for C30H27F6NNaO3 [M+Na]+ 586.1787, found 586.1784. 
tert-Butyl (3aR*,4R*,9aR*)-9a-(3-methoxyphenyl)-4-phenyl-2,3,3a,9a-
tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (5n): White 
solid. Rf = 0.50 (hexane/ethyl acetate 5:1). Melting point: 158-160 °C. 1H 
NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.35–7.20 (m, 5H), 7.16–7.12 (m, 
2H), 7.06 (d, J = 8.0 Hz, 1H), 6.97–6.92 (m, 2H), 6.87–6.82 (m, 3H), 3.99 
(d, J = 5.2 Hz, 1H), 3.85–3.79 (m, 1H), 3.76 (s, 3H), 3.53 (td, J = 10.7, 
6.8 Hz, 1H), 2.77–2.66 (m, 1H), 2.01–1.87 (m, 1H), 1.64 (dt, J = 12.4, 6.4 
Hz, 1H), 1.21 (s, 9H). 13C NMR (100 MHz, 330K, CDCl3): δ (ppm) 159.7, 
153.8, 153.7, 144.8, 140.8, 129.5, 129.1, 128.9, 128.4, 128.2, 127.0, 
121.9, 120.5, 117.9, 116.3, 112.7, 111.8, 94.4, 79.9, 55.2, 53.4, 46.7, 
41.0, 28.0, 23.9. HMRS: calculated for C29H31NNaO4 [M+Na]+ 480.2145, 
found 480.2145. 
tert-butyl (3aR*,4R*,9aR*)-4-phenyl-9a-(thiophen-2-yl)-2,3,3a,9a-
tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (5o-diast. 1): 
White solid. Rf = 0.54 (hexane/ethyl acetate 5:1). Melting point: 181-
183 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.37–7.20 (m, 5H), 
7.17 (d, J = 6.9 Hz, 2H), 7.03 (d, J = 8.1 Hz, 1H), 6.97 (d, J = 2.3 Hz, 1H), 
6.95–6.91 (m, 1H), 6.89–6.82 (m, 2H), 4.14 (d, J = 5.2 Hz, 1H), 3.76 (app 
t, J = 9.8 Hz, 1H), 3.50 (td, J = 10.7, 7.0 Hz, 1H), 2.92–2.76 (m, 1H), 
1.98–1.85 (m, 1H), 1.68–1.55 (m, 1H), 1.30 (s, 9H). 13C NMR (100 MHz, 
330K, CDCl3): δ (ppm) 153.7, 153.1, 146.6, 140.7, 129.6, 128.9, 128.5, 
128.2, 127.1, 126.4, 124.8, 124.4, 121.9, 120.9, 116.7, 92.7, 80.2, 54.6, 
46.4, 41.4, 28.1, 23.6. HMRS: calculated for C26H28NO3S [M+H]+ 
434.1784, found 434.1777. 
tert-butyl (3aR*,4S*,9aR*)-4-phenyl-9a-(thiophen-2-yl)-2,3,3a,9a-
tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (5o-diast. 2): 
White solid. Rf = 0.40 (hexane/ethyl acetate 5:1). Melting point: 120-
122 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.28–7.24 (m, 1H), 
7.16–7.08 (m, 4H), 7.02 (d, J = 4.9 Hz, 1H), 6.97–6.86 (m, 4H), 6.77 (d, J 
= 2.8 Hz, 1H), 6.74–6.69 (m, 1H), 4.08 (d, J = 4.2 Hz, 1H), 3.75–3.63 (m, 
1H), 3.06–3.02 (m, 1H), 2.23 (td, J = 12.5, 6.8 Hz, 1H), 1.93–1.81 (m, 
1H), 1.30 (s, 9H). 13C NMR (100 MHz, 330K, CDCl3): δ (ppm) 154.0, 
153.5, 148.9, 143.1, 130.1, 128.7, 128.6, 128.5, 126.6, 126.1, 124.9, 
124.5, 122.1, 118.1, 93.2, 80.5, 55.6, 46.0, 44.8, 28.5, 28.1. HMRS: 
calculated for C26H28NO3S [M+H]+ 434.1784, found 434.1769. 
tert-Butyl (3aR*,4R*,9aR*)-9a-(4-bromophenyl)-6-methoxy-4-phenyl-
2,3,3a,9a-tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (5p): 
White solid. Rf = 0.58 (hexane/ethyl acetate 5:1). Melting point: 182-
184 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.47 (d, J = 8.7 Hz, 
2H), 7.38–7.22 (m, 5H), 7.17–7.10 (m, 2H), 6.99 (d, J = 8.8 Hz, 1H), 6.83 
(ddd, J = 8.8, 3.0, 0.9 Hz, 1H), 6.41 (dd, J = 3.0, 1.1 Hz, 1H), 3.92 (d, J = 
5.2 Hz, 1H), 3.82 (app t, J = 9.8 Hz, 1H), 3.65 (s, 3H), 3.56–3.42 (m, 1H), 
2.72–2.60 (m, 1H), 2.01–1.86 (m, 1H), 1.64 (dt, J = 12.7, 6.5 Hz, 1H), 
1.23 (s, 9H). 13C NMR (100 MHz, 330K, CDCl3): δ (ppm) 153.8, 153.6, 
147.5, 142.4, 140.3, 131.2, 129.5, 128.5, 127.4, 127.2, 122.7, 121.2, 
117.0, 114.4, 114.1, 94.0, 80.1, 55.6, 53.5, 46.6, 41.3, 28.0, 23.9. HMRS: 
calculated for C29H30BrNNaO4 [M+Na]+ 558.1250, found 558.1261. 
tert-Butyl (3aR*,4R*,9aR*)-9a-(4-bromophenyl)-8-methyl-4-phenyl-
2,3,3a,9a-tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (5q): 
White solid. Rf = 0.50 (hexane/ethyl acetate 5:1). Melting point: 219-
212 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.47 (d, J = 8.2 Hz, 
2H), 7.34–7.26 (m, 3H), 7.22 (d, J = 8.2 Hz, 2H), 7.16–7.10 (m, 3H), 6.77 
(t, J = 7.4 Hz, 1H), 6.70 (d, J = 7.4 Hz, 1H), 3.96 (d, J = 4.4 Hz, 1H), 3.84 
(t, J = 9.4 Hz, 1H), 3.56–3.43 (m, 1H), 2.75–2.63 (m, 1H), 2.36 (s, 3H), 
2.01–1.84 (m, 1H), 1.72–1.61 (m, 1H), 1.21 (s, 9H).  13C NMR (100 MHz, 
330K, CDCl3): δ (ppm) 153.8, 151.3, 143.0, 140.6, 131.2, 129.5, 129.5, 
128.4, 127.2, 127.0, 126.4, 125.3, 121.8, 121.2, 120.2, 94.3, 80.0, 53.6, 
46.7, 41.1, 28.0, 24.0, 15.9. HMRS: calculated for C29H30BrNNaO3 
[M+Na]+ 542.1301, found 542.1297. 
tert-Butyl (3aR*,4R*,9aR*)-9a-(4-nitrophenyl)-4-(p-tolylethynyl)-
2,3,3a,9a-tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (7a-
major diast.): Yellow solid. Rf = 0.45 (hexane/ethyl acetate 5:1). Melting 
point: 152-154 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 8.22 (d, J = 
9.0 Hz, 2H), 7.65–7.56 (m, 3H), 7.37–7.29 (m, 3H), 7.13 (d, J = 7.9 Hz, 
2H), 7.07 (td, J = 7.5, 1.1 Hz, 1H), 7.02 (d, J = 8.0 Hz, 1H), 3.96 (d, J = 
4.6 Hz, 1H), 3.77 (app t, J = 9.7 Hz, 1H), 3.67 (td, J = 10.4, 7.2 Hz, 1H), 
3.02 (ddd, J = 11.9, 7.1, 4.8 Hz, 1H), 2.36 (s, 3H), 2.30–2.19 (m, 1H), 
1.90–1.77 (m, 1H), 1.24 (s, 9H). 13C NMR (100 MHz, 330K, CDCl3): δ 
(ppm) 153.1, 152.0, 150.9, 147.5, 138.5, 131.6, 129.0, 129.0, 128.3, 
126.3, 123.5, 122.0, 120.6, 119.8, 116.8, 94.3, 85.6, 85.0, 80.7, 52.6, 
46.8, 28.8, 28.0, 23.7, 21.3. HMRS: calculated for C31H30N2NaO5 
[M+Na]+ 533.2046, found 533.2049. 
tert-Butyl (3aR*,4S*,9aR*)-9a-(4-nitrophenyl)-4-(p-tolylethynyl)-
2,3,3a,9a-tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (7a-
minor diast.): Yellow solid. Rf = 0.23 (hexane/ethyl acetate 5:1). Melting 
point: 176-178 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 8.06 (d, J = 
8.6 Hz, 2H), 7.61 (d, J = 8.6 Hz, 2H), 7.39–7.25 (m, 2H), 7.09 (d, J = 7.8 
Hz, 1H), 7.03 (t, J = 7.3 Hz, 1H), 6.93 (d, J = 7.7 Hz, 2H), 6.76 (d, J = 7.7 
Hz, 2H), 3.94 (s, 1H), 3.86–3.64 (m, 2H), 3.17–3.01 (m, 1H), 2.27 (s, 3H), 
2.19–2.06 (m, 1H), 1.93–1.79 (m, 1H), 1.26 (s, 9H). 13C NMR (100 MHz, 
330K, CDCl3): δ (ppm) 153.1, 151.6, 150.8, 147.2, 138.1, 130.9, 129.8, 
129.2, 128.7, 127.1, 122.9, 122.0, 119.8, 119.4, 117.3, 93.0, 88.2, 83.6, 
80.7, 52.1, 46.3, 29.8, 28.0, 26.8, 21.1. HMRS: calculated for 
C31H30N2NaO5 [M+Na]+ 533.2046, found 533.2048. 
tert-Butyl (3aR*,4R*,9aR*)-9a-(4-bromophenyl)-4-(p-tolylethynyl)-
2,3,3a,9a-tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (7b-
major diast.): Yellow solid. Rf = 0.64 (hexane/ethyl acetate 5:1). Melting 
point: 98-100 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.49 (ddd, J 
= 7.6, 1.9, 0.9 Hz, 1H), 7.37 (d, J = 8.4 Hz, 2H), 7.23 (d, J = 8.0 Hz, 2H), 
7.20–7.12 (m, 3H), 7.01 (d, J = 8.0 Hz, 2H), 6.92 (t, J = 7.6, 1H), 6.88 (d, 
J = 8.1 Hz, 1H), 3.86 (d, J = 4.7 Hz, 1H), 3.64 (app t, J = 9.5 Hz, 1H), 
3.52 (td, J = 10.5, 7.1 Hz, 1H), 2.85 (ddd, J = 12.0, 7.0, 4.8 Hz, 1H), 2.25 
(s, 3H), 2.14–2.00 (m, 1H), 1.75–1.60 (m, 1H), 1.13 (s, 9H). 13C NMR 
(100 MHz, 330K, CDCl3): δ (ppm) 153.6, 152.5, 143.0, 138.5, 131.8, 
131.5, 129.2, 129.0, 128.4, 127.3, 121.8, 120.7, 120.2, 116.9, 94.6, 86.4, 
84.9, 80.4, 52.6, 46.9, 28.9, 28.2, 23.7, 21.5. HMRS: calculated for 
C31H30BrNNaO3 [M+Na]+ 566.1301, found 566.1300. 
tert-Butyl (3aR*,4S*,9aR*)-9a-(4-bromophenyl)-4-(p-tolylethynyl)-
2,3,3a,9a-tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (7b-
minor diast.): Yellow solid. Rf = 0.45 (hexane/ethyl acetate 5:1). Melting 
point: 187-189 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.28 (d, J = 
8.7 Hz, 2H), 7.23–7.14 (m, 4H), 6.96 (d, J = 8.1 Hz, 1H), 6.93–6.86 (m, 
3H), 6.76 (d, J = 8.1 Hz, 2H), 3.84 (d, J = 2.6 Hz, 1H), 3.71–3.62 (m, 1H,), 
3.61–3.50 (m, 1H), 2.94 (ddd, J = 11.2, 6.8, 2.6 Hz, 1H), 2.20 (s, 3H), 
2.04–1.93 (m, 1H), 1.83–1.69 (m, 1H), 1.13 (s, 9H). 13C NMR (100 MHz, 
330K, CDCl3): δ (ppm) 153.7, 152.3, 143.0, 138.0, 131.6, 131.1, 129.9, 
129.2, 129.0, 128.2, 121.9, 121.5, 120.4, 120.1, 117.5, 93.7, 88.5, 83.5, 
80.5, 52.3, 46.5, 30.2, 28.3, 27.0, 21.5. HMRS: calculated for 
C31H30BrNNaO3 [M+Na]+ 566.1301, found 566.1310. 
tert-Butyl (3aR*,4R*,9aR*)-9a-[3,5-bis(trifluoromethyl)phenyl]-4-[(4-
methoxyphenyl)ethynyl]2,3,3a,9a-tetrahydrochromeno[2,3-
b]pyrrole-1(4H)-carboxylate (7c-major diast.): Yellow solid. Rf = 0.67 
(hexane/ethyl acetate 5:1). Melting point: 97-99 °C. 1H NMR (400 MHz, 
330K, CDCl3): δ (ppm) 7.81–7.73 (m, 3H), 7.54 (dt, J = 7.6, 1.5 Hz, 1H), 
7.29 (d, J = 8.9 Hz, 2H), 7.21 (ddd, J = 8.0, 7.6, 1.5 Hz, 1H), 6.99 (t, J = 
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7.6 Hz, 1H), 6.92 (d, J = 8.0 Hz, 1H), 6.75 (d, J = 8.9 Hz, 2H), 3.88 (d, J = 
4.5 Hz, 1H), 3.71 (s, 3H), 3.65–3.49 (m, 2H), 3.03–2.87 (m, 1H), 2.22–
2.09 (m, 1H), 1.70 (ddt, J = 12.8, 11.7, 9.5 Hz, 1H), 1.09 (s, 9H). 13C 
NMR (100 MHz, 330K, CDCl3): δ (ppm) 159.9, 153.0, 151.9, 147.1, 133.0, 
132.0 (q, JCF = 33.5 Hz), 129.0, 128.1, 125.7, 123.2 (q, JCF = 271.0 Hz), 
122.3, 121.3, 117.0, 115.0, 114.1, 94.2, 85.1, 84.6, 80.7, 55.2, 53.1, 46.8, 
28.9, 27.8, 23.6. 19F NMR (282 MHz, CDCl3): δ (ppm) 62.7. HMRS: 
calculated for C33H29F6NNaO4 [M+Na]+ 640.1893, found 640.1889. 
tert-Butyl (3aR*,4R*,9aR*)-9a-(3-methoxyphenyl)-4-[(4-
methoxyphenyl)ethynyl]-2,3,3a,9a-tetrahydrochromeno[2,3-
b]pyrrole-1(4H)-carboxylate (7d-major diast.): Yellow solid. Rf = 0.43 
(hexane/ethyl acetate 5:1). Melting point: 91-93 °C. 1H NMR (400 MHz, 
330K, CDCl3): δ (ppm) 7.49 (dt, J = 7.6, 1.4 Hz, 1H), 7.27 (d, J = 8.9 Hz, 
2H), 7.19–7.11 (m, 2H), 6.94–6.84 (m, 4H), 6.77–6.70 (m, 3H), 3.91 (d, J 
= 4.7 Hz, 1H), 3.71 (s, 3H),  3.68 ( s, 3H), 3.67–3.60 (m, 1H), 3.57–3.50 
(m, 1H), 2.91 (ddd, J = 12.0, 6.9, 4.8 Hz, 1H), 2.13–2.01 (m, 1H), 1.72–
1.60 (m, 1H), 1.12 (s, 9H). 13C NMR (100 MHz, 330K, CDCl3): δ (ppm) 
160.0, 159.9, 153.8, 152.7, 145.5, 133.3, 129.4, 128.9, 128.4, 121.5, 
121.0, 117.9, 116.9, 115.5, 114.2, 113.0, 111.8, 94.9, 86.0, 84.5, 80.1, 
55.5, 52.7, 46.9, 29.0, 28.2, 23.7. HMRS: calculated for C32H33NNaO5 
[M+Na]+ 534.2250, found 534.2265. 
tert-Butyl (3aR*,4S*,9aR*)-9a-(3-methoxyphenyl)-4-[(4-
methoxyphenyl)ethynyl]-2,3,3a,9a-tetrahydrochromeno[2,3-
b]pyrrole-1(4H)-carboxylate (7d-minor diast.): Yellow solid. Rf = 0.32 
(hexane/ethyl acetate 5:1). Melting point: 178-180°C. 1H NMR (400 MHz, 
330K, CDCl3): δ (ppm) 7.34 (dd, J = 7.8, 1.6 Hz, 1H), 7.29–7.24 (m, 1H), 
7.16 (t, J = 7.8 Hz, 1H), 7.07 (d, J = 8.1 Hz, 1H), 7.03–6.96 (m, 5H), 
6.76–6.69 (m, 3H), 3.92 (d, J = 3.5 Hz, 1H), 3.78 (s, 3H), 3.67 (s, 3H), 
3.77–3.70 (m, 2H), 3.09–3.00 (m, 1H), 2.16–2.07 (m, 1H), 1.94–1.86 (m, 
1H), 1.22 (s, 9H). 13C NMR (100 MHz, 330K, CDCl3): δ (ppm) 159.4, 
159.2, 152.5, 142.0, 132.9, 129.3, 129.2, 128.7, 128.7, 128.6, 128.3, 
121.5, 118.4, 117.3, 115.4, 113.5, 112.6, 112.4, 94.0, 87.5, 82.8, 79.9, 
55.1, 52.3, 46.1, 30.4, 28.0, 26.8. HMRS: calculated for C32H33NNaO5 
[M+Na]+ 534.2250, found 534.2260. 
tert-Butyl (3aR*,4R*,9aR*)-4-(hex-1-yn-1-yl)-9a-(thiophen-2-yl)-
2,3,3a,9a-tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (7e-
diast. 1): Orange solid. Rf = 0.37 (hexane/ethyl acetate 7:1). Melting 
point: 99-101 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.52 (dt, J = 
7.6, 1.4 Hz, 1H), 7.26–7.19 (m, 2H), 7.01 (td, J = 7.5, 1.2 Hz, 1H), 6.97–
6.91 (m, 3H), 3.90 (s, 1H), 3.71–3.63 (m, 1H), 3.57 (td, J = 10.6, 7.0 Hz, 
1H), 3.03 (ddd, J = 12.1, 7.0, 4.8 Hz, 1H), 2.27 (td, J = 7.0, 2.3 Hz, 2H,), 
2.13–2.03 (m, 1H), 1.69–1.41 (m, 5H), 1.30 (s, 9H), 0.95 (t, J = 7.3 Hz, 
3H). 13C NMR (100 MHz, 330K, CDCl3): δ (ppm) 153.6, 151.9, 147.8, 
128.4, 128.0, 126.5, 124.3, 123.8, 121.8, 121.6, 116.8, 93.2, 84.7, 80.1, 
53.9, 46.3, 31.0, 28.5, 28.0, 23.2, 21.9, 18.4, 13.4. HMRS: calculated for 
C26H32NO3S [M+H]+ 438.2097, found 438.2086. 
tert-Butyl (3aR*,4S*,9aR*)-4-(hex-1-yn-1-yl)-9a-(thiophen-2-yl)-
2,3,3a,9a-tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (7e-
diast. 2): Orange solid. Rf = 0.33 (hexane/ethyl acetate 7:1). Melting 
point: 186-188 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.37 (d, J = 
7.4 Hz, 1H), 7.27–7.22 (m, 1H), 7.15 (dd, J = 5.0, 1.3 Hz, 1H), 7.05 (d, J 
= 7.8 Hz, 1H), 7.00 (td, J = 7.4, 1.2 Hz, 1H), 6.94 (dd, J = 3.6, 1.3 Hz, 1H), 
6.86 (dd, J = 5.0, 3.6 Hz, 1H), 3.80–3.64 (m, 3H), 2.82 (dd, J = 13.3, 7.0 
Hz, 1H), 2.25–2.14 (m, 1H), 2.04–1.92 (m, 3H), 1.42–1.23 (m, 13H), 0.89 
(t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, 330K, CDCl3): δ (ppm) 153.6, 
152.3, 148.7, 128.4, 126.0, 124.1, 124.0, 123.0, 121.9, 117.5, 93.5, 84.0, 
80.1, 78.6, 54.0, 45.4, 30.9, 30.6, 28.1, 26.4, 21.8, 18.3, 13.4. HMRS: 
calculated for C26H32NO3S [M+H]+ 438.2097, found 438.2094. 
tert-Butyl (3aR*,4R*,9aR*)-4-(cyclopropylethynyl)-9a-(4-nitrophenyl)-
2,3,3a,9a-tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (7f-
major diast.): Yellow solid. Rf = 0.55 (hexane/ethyl acetate 5:1). Melting 
point: 92-94 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 8.11–8.04 (m, 
2H), 7.49–7.41 (m, 2H), 7.40 (dt, J = 7.6, 1.4 Hz, 1H), 7.20–7.12 (m, 1H), 
6.93 (td, J = 7.8, 1.1 Hz, 1H), 6.86 (d, J = 7.8 Hz, 1H), 3.70–3.45 (m, 3H), 
2.83–2.70 (m, 1H), 2.10–1.96 (m, 1H), 1.70–1.53 (m, 1H), 1.30–0.94 (m, 
10H), 0.86–0.75 (m, 2H), 0.70–0.62 (m, 2H). 13C NMR (100 MHz, 330K, 
CDCl3): δ (ppm) 153.4, 152.1, 151.2, 147.7, 129.0, 128.4, 126.5, 123.6, 
122.1, 121.3, 116.9, 94.5, 88.5, 80.9, 72.3, 53.0, 47.0, 28.4, 28.3, 23.8, 
8.4, 8.3, 0.07. HMRS: calculated for C27H28N2NaO5 [M+Na]+ 483.1849, 
found 483.1890. 
tert-Butyl (3aR*,4S*,9aR*)-9a-[4-(trifluoromethyl)phenyl]-4-
[(trimethylsilyl)ethynyl]-2,3,3a,9a-tetrahydrochromeno[2,3-b]pyrrole-
1(4H)-carboxylate (7g-major diast.): White solid. Rf = 0.64 
(hexane/ethyl acetate 5:1). Melting point: 106-108 °C. 1H NMR (400 MHz, 
330K, CDCl3): δ (ppm) 7.61–7.57 (m, 2H), 7.53–7.46 (m, 3H), 7.30–7.24 
(m, 1H), 7.03 (td, J = 7.4, 0.9 Hz, 1H), 6.97 (d, J = 8.1 Hz, 1H), 3.78–3.69 
(m, 2H), 3.63 (td, J = 10.5, 7.2 Hz, 1H), 2.97–2.85 (m, 1H), 2.20–2.07 (m, 
1H), 1.75–1.70 (m, 1H), 1.20 (s, 9H), 0.20 (s, 9H). 13C NMR (100 MHz, 
330K, CDCl3): δ (ppm) 153.6, 152.4, 147.9, 130.2 (q, JCF = 33.8 Hz), 
129.1, 128.4, 127.1 (q, JCF = 271.0 Hz), 126.0, 125.4, 121.9, 120.3, 116.9, 
103.7, 94.5, 89.6, 80.6, 52.4, 46.9, 29.2, 28.2, 23.6, 0.2. 19F NMR (282 
MHz, CDCl3): δ (ppm) 62.5. HMRS: calculated for C28H32F3NNaO3Si 
[M+Na]+ 538.1995, found 538.1997. 
tert-Butyl (3aR*,4R*,9aR*)-9a-[4-(trifluoromethyl)phenyl]-4-
[(trimethylsilyl)ethynyl]-2,3,3a,9a-tetrahydrochromeno[2,3-b]pyrrole-
1(4H)-carboxylate (7g-minor diast.): White solid. Rf = 0.55 
(hexane/ethyl acetate 5:1). Melting point: 240-242 °C. 1H RMN (400 MHz, 
330K, CDCl3): δ (ppm) 8.26–8.19 (m, 4H), 8.02–7.93 (m, 2H), 7.75 (d, J 
= 8.5 Hz, 1H), 7.70 (t, J = 7.4 Hz, 1H), 4.49 (d, J = 2.5 Hz, 1H), 4.46–4.33 
(m, 2H), 3.68 (app t, J = 7.5 Hz, 1H), 2.83–2.72 (m, 1H), 2.61–2.46 (m, 
1H), 1.89 (s, 9H), 0.62 (s, 9H). 13C NMR (100 MHz, 330K, CDCl3): δ 
(ppm) 153.6, 152.2, 147.9, 129.9 (q, JCF = 271.0 Hz), 129.8, 129.2, 126.8, 
125.0, 124.6 (q, JCF = 271.0 Hz), 122.0, 120.2, 117.5, 105.3, 93.6, 87.5, 
80.6, 52.2, 46.4, 30.6, 28.2, 27.2, 0.1. 19F NMR (282 MHz, CDCl3): δ 
(ppm) 62.3. HMRS: calculated for C28H32F3NNaO3Si [M+Na]+ 538.1995, 
found 538.2006. 
tert-Butyl (3aR*,4R*,9aR*)-4-(cyclohex-1-en-1-ylethynyl)-9a-(p-tolyl)-
2,3,3a,9a-tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (7h-
major diast.): Yellow solid. Rf = 0.38 (hexane/ethyl acetate 6:1). Melting 
point: 96-99 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.50 (d, J = 
7.6 Hz, 1H), 7.26–7.21 (m, 3H), 7.12 (d, J = 8.5 Hz, 2H), 6.99–6.96 (m, 
2H), 6.12–6.07 (m, 1H), 3.88 (d, J = 4.7 Hz, 1H), 3.73 (app t, J = 9.4 Hz, 
1H), 3.61 (td, J = 10.5, 7.0 Hz, 1H), 2.96–2.82 (m, 1H), 2.35 (s, 3H), 
2.20–2.03 (m, 5H), 1.72–1.56 (m, 5H), 1.20 (s, 9H). 13C NMR (100 MHz, 
330K, CDCl3): δ (ppm) 153.7, 152.5, 140.6, 136.8, 134.3, 128.7, 128.5, 
128.1, 125.1, 121.1, 120.8, 120.6, 116.5, 94.7, 86.1, 84.4, 79.8, 52.5, 
46.6, 29.5, 28.5, 28.0, 25.5, 23.3, 22.3, 21.5, 20.8. HMRS: calculated for 
C31H36NO3 [M+H]+ 470.2689, found 470.2683. 
tert-Butyl (3aR*,4S*,9aR*)-4-(cyclohex-1-en-1-ylethynyl)-9a-(p-tolyl)-
2,3,3a,9a-tetrahydrochromeno[2,3-b]pyrrole-1(4H)-carboxylate (7h-
minor diast.): Yellow solid. Rf = 0.34 (hexane/ethyl acetate 6:1). Melting 
point: 192-194 °C. 1H NMR (400 MHz, 330K, CDCl3): δ (ppm) 7.31–7.20 
(m, 4H), 7.09–7.02 (m, 3H), 6.96 (td, J = 7.4, 1.2 Hz, 1H), 5.70–5.64 (m, 
1H), 3.82 (d, J = 3.6 Hz, 1H), 3.78–3.64 (m, 2H), 2.89 (ddd, J = 10.2, 6.7, 
3.7 Hz, 1H), 2.31 (s, 3H), 2.14–2.01 (m, 1H), 1.98 (bs, 2H), 1.84–1.80 (m, 
1H), 1.76 (bs, 2H), 1.55–1.46 (m, 4H), 1.21 (s, 9H). 13C NMR (100 MHz, 
330K, CDCl3): δ (ppm) 153.7, 152.5, 140.6, 136.4, 133.7, 129.3, 128.6, 
128.3, 125.8, 121.3, 121.0, 120.5, 117.2, 94.2, 86.3, 84.7, 79.8, 52.3, 
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46.0, 30.1, 29.0, 28.0, 26.6, 25.5, 22.3, 21.5, 20.1. HMRS: calculated for 
C31H36NO3 [M+H]+ 470.2689, found 470.2682. 
Methyl (3aR*,4R*,9aR*)-9a-(4-bromophenyl)-4-[(4-
methoxyphenyl)ethynyl]-2,3,3a,9a-tetrahydrochromeno[2,3-
b]pyrrole-1(4H)-carboxylate (7i-major diast.): Yellow solid. Rf = 0.41 
(hexane/ethyl acetate 5:1). Melting point: 93-95 °C. 1H NMR (400 MHz, 
330K, CDCl3): δ (ppm) 7.50 (d, J = 7.6 Hz, 1H), 7.38 (d, J = 8.7 Hz, 2H), 
7.28 (d, J = 8.8 Hz, 2H), 7.21–7.14 (m, 3H), 6.97–6.90 (m, 2H), 6.75 (d, J 
= 8.8 Hz, 2H), 3.88 (d, J = 4.7 Hz, 1H), 3.72 (s, 3H), 3.70–3.65 (m, 1H), 
3.58 (td, J = 10.5, 7.1 Hz, 1H), 3.48 (s, 3H), 2.86 (ddd, J = 12.0, 7.0, 4.8 
Hz, 1H), 2.19–2.06 (m, 1H), 1.79–1.65 (m, 1H). 13C NMR (100 MHz, 
330K, CDCl3): δ (ppm) 160.0, 154.9, 152.2, 141.9, 133.3, 131.8, 129.1, 
128.5, 127.2, 122.1, 121.9, 120.6, 117.0, 115.3, 114.3, 94.8, 85.5, 84.7, 
55.5, 52.5, 52.3, 47.2, 28.8, 23.9. HMRS: calculated for C28H24BrNNaO4 
[M+Na]+ 540.0780, found 540.0792. 
Methyl (3aR*,4S*,9aR*)-9a-(4-bromophenyl)-4-[(4-
methoxyphenyl)ethynyl]-2,3,3a,9a-tetrahydrochromeno[2,3-
b]pyrrole-1(4H)-carboxylate (7i-minor diast.): Yellow solid. Rf = 0.30 
(hexane/ethyl acetate 5:1). Melting point: 75-77 °C. 1H NMR (400 MHz, 
330K, CDCl3): δ (ppm) 7.29 (d, J = 8.8 Hz, 2H), 7.25–7.20 (m, 3H), 7.20–
7.15 (m, 1H), 7.00 (d, J = 8.3 Hz, 1H), 6.90 (td, J = 7.5, 1.2 Hz, 1H), 6.82 
(d, J = 8.9 Hz, 2H), 6.65 (d, J = 8.9 Hz, 2H), 3.85 (d, J = 2.8 Hz, 1H), 
3.81–3.59 (m, 5H), 3.48 (s, 3H), 3.00–2.88 (m, 1H), 2.08–1.98 (m, 1H), 
1.88–1.74 (m, 1H). 13C NMR (100 MHz, 330K, CDCl3): δ (ppm) 159.6, 
152.1, 142.0, 133.1, 131.3, 129.9, 129.2, 128.1, 122.0, 120.3, 117.6, 
115.3, 114.1, 93.9, 87.6, 83.5, 55.4, 52.4, 51.9, 46.6, 30.0, 27.1. HMRS: 
calculated for C28H24BrNNaO4 [M+Na]+ 540.0780, found 540.0786. 
(3aR*,4R*,9aR*)-9a-(4-bromophenyl)-4-[(4-methoxyphenyl)ethynyl]-
1-tosyl-1,2,3,3a,4,9a-hexahydrochromeno[2,3-b]pyrrole (7j-major 
diast.): Orange solid. Rf = 0.26 (hexane/ethyl acetate 7:1). Melting point: 
170-172 °C. 1H NMR (400 MHz, CDCl3): δ (ppm) 7.80 (d, J = 8.2 Hz, 2H), 
7.74 (d, J = 8.7 Hz, 1H), 7.5 –7.44 (m, 2H), 7.38 (d, J = 8.7 Hz, 2H), 
7.35–7.28 (m, 4H), 7.20 (t, J = 7.6 Hz, 1H), 6.97 (app t, J = 7.0 Hz, 1H), 
6.82 (d, J = 8.8 Hz, 2H), 6.67 (d, J = 7.6 Hz, 1H), 3.84–3.71 (m, 5H), 3.51 
(t, J = 9.6 Hz, 1H), 3.09–2.95 (m, 1H), 2.46 (s, 3H), 2.29–2.16 (m, 1H), 
1.74–1.60 (m, 1H). 13C NMR (75 MHz, CDCl3): δ (ppm) 159.6, 151.5, 
143.6, 140.0, 136.5, 133.1, 131.5, 129.8, 129.1, 128.6, 127.9, 127.1, 
122.5, 121.7, 119.1, 115.7, 114.8, 113.9, 96.6, 85.0, 84.1, 55.3, 51.3, 
47.8, 28.1, 23.5, 21.6. HMRS: calculated for C33H29BrNO4S [M+H]+ 
614.0995, found 614.0972. 
(3aR*,4S*,9aR*)-9a-(4-bromophenyl)-4-[(4-methoxyphenyl)ethynyl]-1-
tosyl-1,2,3,3a,4,9a-hexahydrochromeno[2,3-b]pyrrole (7j-minor 
diast.): Orange solid. Rf = 0.11 (hexane/ethyl acetate 7:1). Melting point: 
184-186 °C. 1H NMR (400 MHz, CDCl3): δ (ppm) 7.82 (d, J = 8.3 Hz, 2H), 
7.56–7.48 (m, 3H), 7.41 (d, J = 8.7 Hz, 2H), 7.37–7.31 (m, 4H), 7.22 (app 
t, J = 7.8 Hz, 1H), 6.99 (app t, J = 7.0 Hz, 1H), 6.84 (d, J = 8.8 Hz, 2H), 
6.69 (d, J = 7.4 Hz, 1H), 3.82–3.79 (m, 5H), 3.53 (app t, J = 8.9 Hz, 1H), 
3.12–2.96 (m, 1H), 2.48 (s, 3H), 2.26–2.16 (m, 1H), 1.81–1.64 (m, 1H). 
13C NMR (75 MHz, CDCl3): δ (ppm) 159.6, 151.5, 143.5, 140.0, 136.6, 
133.1, 131.5, 129.1, 128.9, 128.6, 127.9, 122.5, 121.7, 119.2, 115.7, 
114.8, 113.9, 96.6, 85.0, 84.2, 55.3, 51.4, 47.9, 28.1, 23.5, 21.6. HMRS: 
calculated for C33H28BrNNaO4S [M+Na]+ 636.0814, found 636.0812. 
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